CTOs on the Move


 
EXOS is a leader in the field of human performance, a category it created more than 15 years ago. Today, EXOS employs more than 3,500 people in over 400 locations worldwide. With award-winning facilities, technology, and services, EXOS helps people take control of their health and performance so they can achieve what matters most to them. EXOS is trusted by hundreds of clients, including one-quarter of Fortune 100 companies, world champions in sports, and leaders in health care, military, and community organizations.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.teamexos.com
  • 2629 East Rose Garden Lane
    Phoenix, AZ USA 85050
  • Phone: 480.449.9000

Executives

Name Title Contact Details
Yvette Pasqua
Chief Technology Officer Profile
Thomas Glaser
Chief Information Security Officer Profile

Similar Companies

LifeSeasons

Supplements that address your changing health needs through every phase of life. Formulated for Life. Get in touch: Help@LifeSeasons.com.

Eastern Maine Healthcare Systems

Eastern Maine Healthcare Systems (EMHS) is committed to delivering quality and cost-effective patient care despite the difficult healthcare environment that's challenging the nation and the residents of Maine.

American Nurses Union

American Nurses Union is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.

Encompass Health System

Encompass Health System is a West Des Moines, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.